APGE
Price
$64.22
Change
-$0.67 (-1.03%)
Updated
Feb 5, 02:23 PM (EDT)
Capitalization
4.43B
33 days until earnings call
Intraday BUY SELL Signals
DNTH
Price
$47.80
Change
-$0.33 (-0.69%)
Updated
Feb 5, 02:43 PM (EDT)
Capitalization
2.08B
Intraday BUY SELL Signals
Interact to see
Advertisement

APGE vs DNTH

Header iconAPGE vs DNTH Comparison
Open Charts APGE vs DNTHBanner chart's image
Apogee Therapeutics
Price$64.22
Change-$0.67 (-1.03%)
Volume$100
Capitalization4.43B
Dianthus Therapeutics
Price$47.80
Change-$0.33 (-0.69%)
Volume$200
Capitalization2.08B
APGE vs DNTH Comparison Chart in %
APGE
Daily Signal:
Gain/Loss:
DNTH
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
APGE vs. DNTH commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGE is a StrongBuy and DNTH is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (APGE: $64.88 vs. DNTH: $48.13)
Brand notoriety: APGE and DNTH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APGE: 73% vs. DNTH: 128%
Market capitalization -- APGE: $4.43B vs. DNTH: $2.08B
APGE [@Biotechnology] is valued at $4.43B. DNTH’s [@Biotechnology] market capitalization is $2.08B. The market cap for tickers in the [@Biotechnology] industry ranges from $119.38B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APGE’s FA Score shows that 0 FA rating(s) are green whileDNTH’s FA Score has 1 green FA rating(s).

  • APGE’s FA Score: 0 green, 5 red.
  • DNTH’s FA Score: 1 green, 4 red.
According to our system of comparison, DNTH is a better buy in the long-term than APGE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APGE’s TA Score shows that 5 TA indicator(s) are bullish while DNTH’s TA Score has 6 bullish TA indicator(s).

  • APGE’s TA Score: 5 bullish, 5 bearish.
  • DNTH’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, DNTH is a better buy in the short-term than APGE.

Price Growth

APGE (@Biotechnology) experienced а -8.22% price change this week, while DNTH (@Biotechnology) price change was -4.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.81%. For the same industry, the average monthly price growth was +0.47%, and the average quarterly price growth was +32.90%.

Reported Earning Dates

APGE is expected to report earnings on Mar 10, 2026.

Industries' Descriptions

@Biotechnology (-3.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APGE($4.43B) has a higher market cap than DNTH($2.08B). DNTH YTD gains are higher at: 16.792 vs. APGE (-14.043). DNTH has higher annual earnings (EBITDA): -139.9M vs. APGE (-282.33M). APGE has more cash in the bank: 527M vs. DNTH (403M). DNTH has less debt than APGE: DNTH (1.29M) vs APGE (9.85M). DNTH has higher revenues than APGE: DNTH (3.08M) vs APGE (0).
APGEDNTHAPGE / DNTH
Capitalization4.43B2.08B213%
EBITDA-282.33M-139.9M202%
Gain YTD-14.04316.792-84%
P/E RatioN/A3.24-
Revenue03.08M-
Total Cash527M403M131%
Total Debt9.85M1.29M767%
FUNDAMENTALS RATINGS
DNTH: Fundamental Ratings
DNTH
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
19
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
66
SEASONALITY SCORE
1..100
10

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APGEDNTH
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
65%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 7 days ago
79%
Declines
ODDS (%)
Bearish Trend 7 days ago
67%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
APGE
Daily Signal:
Gain/Loss:
DNTH
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JNGSX12.750.14
+1.11%
Janus Henderson Global Real Estate D
CAMZX17.960.16
+0.90%
Cambiar Small Cap Instl
TGRIX13.87-0.11
-0.79%
American Century International Gr I
GGOUX20.06-0.37
-1.81%
Goldman Sachs Mid Cap Growth R6
VAFAX27.30-0.72
-2.57%
Invesco American Franchise A

APGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with SYRE. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
-5.82%
SYRE - APGE
66%
Loosely correlated
-3.66%
VRDN - APGE
57%
Loosely correlated
-4.80%
CGON - APGE
53%
Loosely correlated
-1.10%
DNTH - APGE
50%
Loosely correlated
-8.25%
NUVL - APGE
50%
Loosely correlated
-2.03%
More

DNTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNTH has been loosely correlated with VRDN. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if DNTH jumps, then VRDN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNTH
1D Price
Change %
DNTH100%
-8.25%
VRDN - DNTH
59%
Loosely correlated
-4.80%
SYRE - DNTH
59%
Loosely correlated
-3.66%
COGT - DNTH
57%
Loosely correlated
-1.15%
ATOS - DNTH
56%
Loosely correlated
-4.34%
SVRA - DNTH
53%
Loosely correlated
-5.30%
More